Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001144204-14-057477
Filing Date
2014-09-24
Accepted
2014-09-24 09:02:54
Documents
16

Document Format Files

Seq Description Document Type Size
1 RULE 424(B)(3) v389897_424b3.htm 424B3 65042
2 GRAPHIC logo.jpg GRAPHIC 13891
3 GRAPHIC page01.jpg GRAPHIC 44791
4 GRAPHIC page02.jpg GRAPHIC 194519
5 GRAPHIC page03.jpg GRAPHIC 63251
6 GRAPHIC page04.jpg GRAPHIC 88209
7 GRAPHIC page05.jpg GRAPHIC 60282
8 GRAPHIC page06.jpg GRAPHIC 58859
9 GRAPHIC page07.jpg GRAPHIC 66164
10 GRAPHIC page08.jpg GRAPHIC 63901
11 GRAPHIC page09.jpg GRAPHIC 42038
12 GRAPHIC page10.jpg GRAPHIC 52716
13 GRAPHIC page11.jpg GRAPHIC 52313
14 GRAPHIC page12.jpg GRAPHIC 58789
15 GRAPHIC page13.jpg GRAPHIC 78949
16 GRAPHIC page14.jpg GRAPHIC 87949
  Complete submission text file 0001144204-14-057477.txt   1482591
Mailing Address 675 ARAPEEN DRIVE, SUITE 202 SALT LAKE CITY X1 84108
Business Address 675 ARAPEEN DRIVE, SUITE 202 SALT LAKE CITY X1 84108 801 994 7383
Lipocine Inc. (Filer) CIK: 0001535955 (see all company filings)

IRS No.: 990370688 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-190897 | Film No.: 141117271
SIC: 2834 Pharmaceutical Preparations